JPRN-UMIN000010294招募中2 期
Efficacy and safety of early fibrinogen concentrate substitution therapy for severe trauma patients receiving massive transfusions: prospective single arm clinical trial - Pilot study of early fibrinogen concentrate substitution therapy for severe trauma patients
Saitama Medical Center, Saitama Medical University0 个研究点目标入组 30 人开始时间: 2013年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)history of venous thromboembolism (2)thrombotic diathesis (such as antithrombin deficiency,Protein S/C deficiency,antiphospholipid antibody syndrome) (3)Agreement acquisition is impossible from the patient and the family.
研究者
相似试验
招募中
2 期
Efficacy and safety of prehospital fibrinogen early in severe trauma study: A feasibility phase II study (PRE-FEISTY II) (Stage 1).Acute traumatic haemorrhageBlood - Clotting disordersEmergency medicine - Other emergency careInjuries and Accidents - Other injuries and accidentsACTRN12623000812695ew South Wales Ambulance23
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency - NDCongenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 9.1Level: LLTClassification code 10016075EUCTR2007-004088-22-ITCSL BEHRING GmbH23
进行中（未招募）
不适用
Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiencyFibrinogen Concentrate (Human) (FCH) - efficacy and safetyCongenital fibrinogen deficiency (afibrinogenemia, severe hypofibrinogenemia)MedDRA version: 12.0Level: LLTClassification code 10016075Term: Factor I deficiencyEUCTR2007-004088-22-DECSL Behring GmbH23
尚未招募
3 期
The administration of fibrinogen concentrate (a component of blood involved in clotting process) to be given to those women who, after delivery of babies, develop severe bleeding to establish if this drug will prevent further blood loss or reduce the volume of blood loss.Post partum haemorrhageReproductive Health and Childbirth - Childbirth and postnatal careBlood - Clotting disordersACTRN12614000691640Auckland City Hospital245
已完成
不适用
Effect of prophylactic fibrinogen on post operative bleeding in coronary artery bypass graft surgeryHemorrhage.Hemorrhage, not elsewhere classifiedIRCT201011085140N1Tehran University of Medical Sciences60